PLGA doping of PCL affects the plastic potential of human mesenchymal stem cells, both in the presence and absence of biological stimuli

Journal of Biomedical Materials Research - Part A

Volumn 89, Issue 1, 2009, Pages 1-12

  Curran, J M ^a   Tang, Z ^a   Hunt, J A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Differentiation; Mesenchymal stem cells; PCL; PLGA; Properties; Surface

Indexed keywords

DIFFERENTIATION; MESENCHYMAL STEM CELLS; PCL; PLGA; PROPERTIES;

ADHESION; CELL ADHESION; CELL CULTURE; CELLS; COLLAGEN; ETHYLENE; FLOWCHARTING; FOURIER TRANSFORM INFRARED SPECTROSCOPY; OXIDE FILMS;

SURFACES;

COLLAGEN TYPE 1; COLLAGEN TYPE 2; F ACTIN; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; POLYCAPROLACTONE; POLYGLACTIN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9;

ARTICLE; BONE DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CHONDROGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROPHILICITY; IMMUNOHISTOCHEMISTRY; INFRARED SPECTROSCOPY; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; HUMANS; LACTIC ACID; MATERIALS TESTING; MESENCHYMAL STEM CELLS; OSTEOGENESIS; POLYESTERS; POLYGLYCOLIC ACID; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 62249101397     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31966     Document Type: Article

References (20)

1. Williams DF. To engineer is to create: The link between engineering and regeneration. Trends Biotechnol 2006;24:4-8.
2. Engelberg I, Kohn J. Physico-mechanical properties of degradable polymers used in medical applications: A comparative study. Biomaterials 1991;12:292-304.
3. Schantz JT, Hutmacher DW, Ng KW, Khor HL, Lim MT, Teoh SH. Evaluation of a tissue-engineered membrane-cell construct for guided bone regeneration. Int J Oral Maxillofac Implants 2002;17:161-174.
4. Thomson RC, Giordano GG, Collier JH, Ishaug SL, Mikos AG, Lahiri-Munir D, Garcia CA. Manufacture and characterization of poly(alpha-hydroxy ester) thin films as temporary substrates for retinal pigment epithelium cells. Biomaterials 1996;17:321-327.
5. Ueda H, Tabata Y. Polyhydroxyalkanonate derivatives in current clinical applications and trials. Adv Drug Deliv Rev 2003;55:501-518.
6. Calvert JW, Marra KG, Cook L, Kumta PN, DiMilla PA, Weiss LE. Characterization of osteoblast-like behavior of cultured bone marrow stromal cells on various polymer surfaces. J Biomed Mater Res 2000;52:279-284.
7. Jones DS, Djokic J, McCov CP, Gorman SP. Poly(epsilon-cap-rolactone) and poly(epsilon-caprolactone)-polyvinylpyrroli-done-iodine blends as ureteral biomaterials: Characterisation of mechanical and surface properties, degradation and resistance to encrustation in vitro. Biomaterials 2002;23:4449-4458.
8. Marietta G, Ciapetti G, Satriano C, Pagani S, Baldini N. The effect of irradiation modification and RGD sequence adsorption on the response of human osteoblasts to polycaprolactone. Biomaterials 2005;26:4793-4804.
9. Sahoo S, Ouyang H, Goh JC, Tay TE, Toh SL. Characterization of a novel polymeric scaffold for potential application in tendon/ligament tissue engineering. Tissue Eng 2006;12:91-99.
10. Tang ZG, Black RA, Curran JM, Hunt JA, Rhodes NP, Williams DF. Surface properties and biocompatibility of solventcast poly[-caprolactone] films. Biomaterials 2004;25:4741-4748.
11. Tang ZG, Callaghan JT, Hunt JA. The physical properties and response of osteoblasts to solution cast films of PLGA doped polycaprolactone. Biomaterials 2005;26:6618-6624.
12. Tang ZG, Hunt JA. The effect of PLGA doping of polycaprolactone films on the control of osteoblast adhesion and proliferation in vitro. Biomaterials 2006;27:4409-4418.
13. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001;226:507-520.
14. Curran JM, Chen R, Hunt JA. Controlling the phenotvpe and function of mesenchymal stem cells in vitro by adhesion to silane-modified clean glass surfaces. Biomaterials 2005;26:7057-7067.
15. Curran JM, Chen R, Hunt JA. The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to the cell substrate. Biomaterials 2006;27:4783-4793.
16. Buckley KA, Golding SL, Rice JM, Dillon JP, Gallagher JA. Release and interconversion of P2 receptor agonists by human osteoblast-like cells. FASEB J 2003;17:1401-1410.
17. Elzein T, Nasser-Eddine M, Delaite C, Bistac S, Dumas P. FTIR study of polycaprolactone chain organization at interfaces. J Colloid Interface Sci 2004;273:381-387.
18. Marietta G, Ciapetti G, Satriano C, Perut F, Salerno M, Baldini N. Improved osteogenic differentiation of human marrow stromal cells cultured on ion-induced chemically structured poly-epsilon-caprolactone. Biomaterials 2007;28:1132-1140.
19. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004;6:483-495.
20. Meyers VE, Zayzafoon M, Douglas JT, McDonald JM. RhoA and cytoskeletal disruption mediate reduced osteohistogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity. J Bone Miner Res 2005;20:1858-1866.